Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial
| Autor: | Niemeyer–van der Kolk, Tessa, Buters, Thomas P., Krouwels, Lara, Boltjes, Jiry, de Kam, Marieke L., van der Wall, Hein, van Alewijk, Dirk C.J.G., van den Munckhof, Ellen H.A., Becker, Martin J., Feiss, Gary, Florencia, Edwin F., Prens, Errol P., Moerland, Matthijs, Burggraaf, Jacobus, Rissmann, Robert, van Doorn, Martijn B.A. |
|---|---|
| Zdroj: | In Journal of the American Academy of Dermatology April 2022 86(4):854-862 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect